Methodist Hospital-San Antonio

San Antonio, Texas 78229

2 studies enrolling now · 10 studies all time

What they study most

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aortic Valve Stenosis, Atrial Fibrillation Paroxysmal, Chronic Heart Failure, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Coronary Artery Disease, Heart Failure, High-Risk Percutaneous Coronary Intervention

Studies at this site

• Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study — Recruiting now
• Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function — Running, not enrolling
• Evolut™ EXPAND TAVR II Pivotal Trial — Running, not enrolling
• Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation — Stopped early
• Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients — Running, not enrolling
• Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System — Paused
• Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol — Enrolling by invitation
• HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis — Running, not enrolling
• Destination Therapy Post Approval Study — Running, not enrolling
• An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) — Completed